Current treatments for AD mainly involve acetylcholinesterase inhibitors, such as donepezil, for mild to severe dementia, and N-methyl-D-aspartic acid receptor antagonists, such as memantine, for moderate to severe dementia (Arvanitakis et al., 2019). The gene discussed is ACHE; the disease is dementia.